Fibromyalgia Studies
Fibromyalgia
Phase 2/3Active
Key Facts
About Pacific Clinical Research Medical Group
Pacific Clinical Research Medical Group is a long-established, private clinical research site organization that conducts Phase II-IV clinical trials for pharmaceutical sponsors, predominantly in psychiatry and neurology. Its business model is service-based, generating revenue by contracting with sponsors to recruit patients, administer trial protocols, and collect data. The company operates from a single physical site in Southern California and leverages its experienced medical team to attract trial participants by offering complementary care and medication. It occupies a niche as an investigative site within the broader clinical trial ecosystem.
View full company profileTherapeutic Areas
Other Fibromyalgia Drugs
| Drug | Company | Phase |
|---|---|---|
| SP-104 | SCILEX | Preclinical/Phase 1 |
| Sequential Dialysis Technique | Halberd | Discovery |
| Stanza | Swing Therapeutics | Approved |
| Fibromyalgia Biomarkers | Paradise Genomics | Discovery |
| SyqeAir Inhaler – Fibromyalgia | Syqe Medical | Commercial |
| AXS-14 | Axsome Therapeutics | Phase 3 |
| SP-104 (low-dose naltrexone DR capsules) | Scilex Holding | Preclinical |